Welcome to our dedicated page for DEUTSCHE BANK AKTIENGESELLSCHAFT SEC filings (Ticker: DZZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DEUTSCHE BANK AKTIENGESELLSCHAFT's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DEUTSCHE BANK AKTIENGESELLSCHAFT's regulatory disclosures and financial reporting.
Deutsche Bank AG furnished a Form 6‑K that attaches its Earnings Report as of September 30, 2025 (Exhibit 99.1, prepared under IASB IFRS) and a capitalization table as of September 30, 2025 (Exhibit 99.2). The filing is incorporated by reference into Registration Statement No. 333-278331.
The company explains the difference between EU IFRS using the EU carve‑out for fair value macro hedges and IASB IFRS (no carve‑out); the attached Earnings Report reflects IASB IFRS, with the EU carve‑out impact described in its basis of preparation. The report includes a forward‑looking statements disclaimer and lists non‑GAAP measures (e.g., adjusted costs, tangible equity, returns), with definitions referenced in Exhibit 99.1 and the 2024 Form 20‑F. The “Risks and Opportunities” section in Exhibit 99.1 supplements, but does not replace, the 2024 Form 20‑F Risk Factors.